Biochemical and structural characterisation of a protozoan beta-carbonic anhydrase from Trichomonas vaginalis
Autor: | Latifeh Azizi, Vesa P. Hytönen, Simona Maria Monti, Claudiu T. Supuran, Giuseppina De Simone, Reza Zolfaghari Emameh, Martina Buonanno, Linda J Urbański, Marianne Kuuslahti, Andrea Angeli, Seppo Parkkila, Anna Di Fiore |
---|---|
Rok vydání: | 2020 |
Předmět: |
crystal structure
Protein Conformation RM1-950 medicine.disease_cause 01 natural sciences trichomonas vaginalis Carbonic anhydrase Drug Discovery medicine Parasite hosting Beta (finance) Carbonic Anhydrases Pharmacology chemistry.chemical_classification Antiinfective agent Trichomoniasis biology protozoan 010405 organic chemistry Chemistry Active site General Medicine medicine.disease 0104 chemical sciences 010404 medicinal & biomolecular chemistry Enzyme Biochemistry kinetics biology.protein Original Article Trichomonas vaginalis Therapeutics. Pharmacology beta carbonic anhydrase Research Article |
Zdroj: | Journal of Enzyme Inhibition and Medicinal Chemistry, Vol 35, Iss 1, Pp 1292-1299 (2020) Journal of Enzyme Inhibition and Medicinal Chemistry article-version (VoR) Version of Record |
ISSN: | 1475-6374 1475-6366 |
Popis: | We report the biochemical and structural characterisation of a beta-carbonic anhydrase (β-CA) from Trichomonas vaginalis, a unicellular parasite responsible for one of the world’s leading sexually transmitted infections, trichomoniasis. CAs are ubiquitous metalloenzymes belonging to eight evolutionarily divergent groups (α, β, γ, δ, ζ, η, θ, and ι); humans express only α-CAs, whereas many clinically significant pathogens express only β- and/or γ-CAs. For this reason, the latter two groups of CAs are promising biomedical targets for novel antiinfective agents. The β-CA from T. vaginalis (TvaCA1) was recombinantly produced and biochemically characterised. The crystal structure was determined, revealing the canonical dimeric fold of β-CAs and the main features of the enzyme active site. The comparison with the active site of human CA enzymes revealed significant differences that can be exploited for the design of inhibitors selective for the protozoan enzyme with respect to the human ones. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |